The company’s sales revenue rose to 326.7 million levs in the period under review, from 297.4 million levs last year, Sopharma Trading said in a bourse filing.
Cost of goods sold increased to 301.26 million levs in January-June, from 274.8 million levs in the corresponding period of 2016.
Sopharma Trading is a unit of Bulgarian pharmaceuticals producer Sopharma [BUL:3JR].
(1 euro = 1.95583 levs)